UBC player suspended for presence of SARM LGD-4033

(Ottawa, Ontario – May 22, 2019) – The Canadian Centre for Ethics in Sport (CCES) confirmed today that Stavros Katsantonis, a U SPORTS football athlete affiliated with the University of British Columbia, received a four-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during out-of-competition doping control on March 22, 2019, revealed the presence of SARM LGD-4033, a prohibited anabolic agent.

On April 26, 2019, the CCES announced an asserted anti-doping rule violation against Mr. Katsantonis in advance of the Canadian Football League’s (CFL) draft, as is permitted by rule 14.3.1 of the Canadian Anti-Doping Program (CADP).

In response to the CCES’s notification of the adverse analytical finding, Mr. Katsantonis waived his right to a hearing thereby accepting the violation and four year proposed sanction, which terminates on May 1, 2023. The athlete, who resides in Bakersfield, California, USA, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates, during the sanction period.

In compliance with rule 7.10 of the CADP, the CCES’s file outcome summary can be found at www.cces.ca/sanctionreg.

About the CCES

The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to making sport better by working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

source: cces.ca

Advocating for football prospects one story at a time.

Comments are closed.